3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
8
Leukemia
6
Leukemia, Myeloid, Acute
5
Myelodysplastic Syndromes
3
Lung Neoplasms
3
Congenital Abnormalities
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Precancerous Conditions
2
Monoclonal Gammopathy of Undetermined Significance
2
Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Colonic Neoplasms
2
Central Nervous System Neoplasms
2
Waldenstrom Macroglobulinemia
1
Uveal Melanoma
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Oligodendroglioma
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Interventions
Surveys and Questionnaires
22
Blood Specimen Collection
13
niraparib
8
Cytoreduction Surgical Procedures
8
Hyperthermic Intraperitoneal Chemotherapy
7
Interviews as Topic
6
Immunohistochemistry
6
olaparib
5
Psychiatric Rehabilitation
5
Polymerase Chain Reaction
5
Magnetic Resonance Spectroscopy
5
Data Collection
5
Carboplatin
5
Amplified Fragment Length Polymorphism Analysis
5
liposomal doxorubicin
4
Geriatric Assessment
4
Bevacizumab
4
1-dodecylpyridoxal
4
Ultrasonography
3
Trabectedin
3
Therapeutics
3
Poly(ADP-ribose) Polymerase Inhibitors
3
Phlebotomy
3
Observation
3
Neoadjuvant Therapy
3
Microarray Analysis
3
Laparoscopy
3
Gene Expression Profiling
3
Flow Cytometry
3
Drug Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Ovarian Neoplasms
×
In Situ Hybridization, Fluorescence
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled